COOPER COMPANIES, INC.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Cooper Companies (COO) opened The Vision Centre in England, a hub for R&D, clinical work, and manufacturing to accelerate contact lens product development. The centre integrates AI and data science, potentially speeding up product launches. Analysts expect $4.9B revenue and $782.6M earnings by 2029, with some forecasting lower figures due to potential pricing pressures and R&D costs.
The Cooper Companies (COO) director Lawrence Erik Kurzius bought 10,000 shares at $54.93 each, totaling $549,300. His total holdings now stand at 31,099 shares. The company reported $4.2B revenue and $570.3M net income over the past year. Kurzius also serves as CEO of McCormick & Co (MCK).
Stifel maintained a Buy rating on Cooper Companies (COO) with a $70 price target, citing competitive positioning and growth projections. The firm expects 3.1% growth for CooperVision by 2027 and mid-single-digit declines for Paragard. COO trades at a P/E of 19.67 and a PEG of 0.44, with a free cash flow yield above 7%. Recent earnings missed revenue expectations, leading to lowered guidance and mixed analyst reactions.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning COO (COOPER COMPANIES, INC.). Coverage has skewed bullish: 1 bullish, 2 neutral, and 0 bearish.
Recent COO coverage spans financial news, corporate actions and insider activity.
In the last 30 days, COO insiders filed 5 SEC Form 4 transactions — 5 purchases ($1.9M) and no sales. The most active reporter was Kurzius Lawrence Erik with 2 filings.
The new hub could accelerate product development and improve margins, but execution risk remains.
Insider buying suggests confidence and may create modest buying pressure.
Analyst upgrade and higher price target may attract buying interest and support the stock.
The activist campaign could create short‑term selling pressure and volatility as shareholders weigh the proxy fight and potential leadership changes.
The larger buyback may boost demand for shares and support the stock price in the near term.
AlphAI scores every news story that mentions COO with an AI model for sentiment and relevance, and aggregates insider trades from COOPER COMPANIES, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Cooper Companies (COO) opened The Vision Centre in England, a hub for R&D, clinical work, and manufacturing to accelerate contact lens product development. The centre integrates AI and data science, potentially speeding up product launches. Analysts expect $4.9B revenue and $782.6M earnings by 2029, with some forecasting lower figures due to potential pricing pressures and R&D costs.
5 min readThe Cooper Companies (COO) director Lawrence Erik Kurzius bought 10,000 shares at $54.93 each, totaling $549,300. His total holdings now stand at 31,099 shares. The company reported $4.2B revenue and $570.3M net income over the past year. Kurzius also serves as CEO of McCormick & Co (MCK).
1 min readStifel maintained a Buy rating on Cooper Companies (COO) with a $70 price target, citing competitive positioning and growth projections. The firm expects 3.1% growth for CooperVision by 2027 and mid-single-digit declines for Paragard. COO trades at a P/E of 19.67 and a PEG of 0.44, with a free cash flow yield above 7%. Recent earnings missed revenue expectations, leading to lowered guidance and mixed analyst reactions.
2 min readJana Partners is pressuring The Cooper Companies (COO) to replace its CEO and board chair, and explore selling its CooperVision and CooperSurgical businesses, citing a 28% stock decline and operational issues. COO reported Q3 revenue of $1.07B, non-GAAP earnings up 4%, and free cash flow up 66% to $273M. Jana argues for leadership changes and potential asset sales, while critics point to flat revenue and inventory pressures.
2 min readCooperCompanies (COO) reported 1% revenue growth and 4% EPS increase in Q3. The company completed a strategic review, deciding to retain CooperSurgical and expand its share buyback program to $3 billion. Operational improvements and cost-cutting measures are planned. Institutional interest slightly increased, with BlackRock as the largest shareholder.
2 min readCooper has opened a Vision Centre Innovation Hub in Southampton, England, to support the growth of its subsidiary, CooperVision. The company's stock has seen a 5-day change of +1.41% and a year-to-date change of +5.26%, but a 31.59% decline from its 1st Jan value.
1 min readCooper Companies (COO) ended its 9-month effort to sell CooperSurgical after bids undervalued the business, according to management. The stock dropped 15% to a 52-week low near $51 after a Q3 miss and cut outlook. The company's core contact lens business, CooperVision, posted flat organic revenue growth, contributing to the guidance cut. Management authorized a $1B share repurchase program, while Bank of America questioned the valuation. COO reported record Q3 free cash flow of $273M.
2 min readJANA Partners sent a letter to The Cooper Companies' board, citing chronic underperformance and calling for an external CEO search, new board chair, and asset sales. The firm highlights poor forecasting, capital allocation, and share price underperformance. JANA urges immediate action to improve shareholder value and engage with potential buyers for CooperVision and CooperSurgical assets.
2 min readKurzius Lawrence Erik purchased 10,000 shares of COOPER COMPANIES, INC. (COO) at $54.93 ($0.55M total) on 2026-09-16.
1 min readCooper Companies director Walter M. Rosebrough Jr. bought 10,000 shares of common stock on September 11 and 14, 2026, at average prices of $54.11 and $54.29 per share. The purchases were made indirectly through a revocable trust and were not part of a preset trading plan.
1 min read
